In conclusion, our data indicate that down-regulation of IMP1 drives PDAC cell-cycle arrest and represents a novel and attractive strategy for overcoming cell proliferation in PDAC and cancer drug resistance. This evidence concerns the gene IGF2BP1 and cancer.